Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
Heart failure (HF) is a global epidemic that contributes to the deterioration of quality of life and its shortening in 1–3% of adult people in the world. Pharmacotherapy of HF should rely on highly effective drugs that improve prognosis and prolong life. Currently, the ESC guidelines from 2021 indic...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/9/5/161 |
| _version_ | 1797498921068527616 |
|---|---|
| author | Krzysztof J. Filipiak Stanisław Surma Monika Romańczyk Bogusław Okopień |
| author_facet | Krzysztof J. Filipiak Stanisław Surma Monika Romańczyk Bogusław Okopień |
| author_sort | Krzysztof J. Filipiak |
| collection | DOAJ |
| description | Heart failure (HF) is a global epidemic that contributes to the deterioration of quality of life and its shortening in 1–3% of adult people in the world. Pharmacotherapy of HF should rely on highly effective drugs that improve prognosis and prolong life. Currently, the ESC guidelines from 2021 indicate that ACEI, ARNI, BB, and SGLT2 inhibitors are the first-line drugs in HF. It is also worth remembering that the use of coenzyme Q10 brought many benefits in patients with HF. Coenzyme Q10 is a very important compound that performs many functions in the human body. The most important function of coenzyme Q10 is participation in the production of energy in the mitochondria, which determines the proper functioning of all cells, tissues, and organs. The highest concentration of coenzyme Q10 is found in the tissue of the heart muscle. As the body ages, the concentration of coenzyme Q10 in the tissue of the heart muscle decreases, which makes it more susceptible to damage by free radicals. It has been shown that in patients with HF, the aggravation of disease symptoms is inversely related to the concentration of coenzyme Q10. Importantly, the concentration of coenzyme Q10 in patients with HF was an important predictor of the risk of death. Long-term coenzyme Q10 supplementation at a dose of 300 mg/day (Q-SYMBIO study) has been shown to significantly improve heart function and prognosis in patients with HF. This article summarizes the latest and most important data on CoQ10 in pathogenesis. |
| first_indexed | 2024-03-10T03:40:11Z |
| format | Article |
| id | doaj.art-0c2d5b4fe2b2486eb529ab7be5234f38 |
| institution | Directory Open Access Journal |
| issn | 2308-3425 |
| language | English |
| last_indexed | 2024-03-10T03:40:11Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj.art-0c2d5b4fe2b2486eb529ab7be5234f382023-11-23T11:33:01ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-05-019516110.3390/jcdd9050161Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10Krzysztof J. Filipiak0Stanisław Surma1Monika Romańczyk2Bogusław Okopień3Institute of Clinical Sciences, Maria-Sklodowska-Curie Medical Academy, 00-001 Warsaw, PolandDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, PolandDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, PolandDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, PolandHeart failure (HF) is a global epidemic that contributes to the deterioration of quality of life and its shortening in 1–3% of adult people in the world. Pharmacotherapy of HF should rely on highly effective drugs that improve prognosis and prolong life. Currently, the ESC guidelines from 2021 indicate that ACEI, ARNI, BB, and SGLT2 inhibitors are the first-line drugs in HF. It is also worth remembering that the use of coenzyme Q10 brought many benefits in patients with HF. Coenzyme Q10 is a very important compound that performs many functions in the human body. The most important function of coenzyme Q10 is participation in the production of energy in the mitochondria, which determines the proper functioning of all cells, tissues, and organs. The highest concentration of coenzyme Q10 is found in the tissue of the heart muscle. As the body ages, the concentration of coenzyme Q10 in the tissue of the heart muscle decreases, which makes it more susceptible to damage by free radicals. It has been shown that in patients with HF, the aggravation of disease symptoms is inversely related to the concentration of coenzyme Q10. Importantly, the concentration of coenzyme Q10 in patients with HF was an important predictor of the risk of death. Long-term coenzyme Q10 supplementation at a dose of 300 mg/day (Q-SYMBIO study) has been shown to significantly improve heart function and prognosis in patients with HF. This article summarizes the latest and most important data on CoQ10 in pathogenesis.https://www.mdpi.com/2308-3425/9/5/161coenzyme Q10heart failure |
| spellingShingle | Krzysztof J. Filipiak Stanisław Surma Monika Romańczyk Bogusław Okopień Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 Journal of Cardiovascular Development and Disease coenzyme Q10 heart failure |
| title | Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 |
| title_full | Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 |
| title_fullStr | Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 |
| title_full_unstemmed | Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 |
| title_short | Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10 |
| title_sort | heart failure do we need new drugs or have them already a case of coenzyme q10 |
| topic | coenzyme Q10 heart failure |
| url | https://www.mdpi.com/2308-3425/9/5/161 |
| work_keys_str_mv | AT krzysztofjfilipiak heartfailuredoweneednewdrugsorhavethemalreadyacaseofcoenzymeq10 AT stanisławsurma heartfailuredoweneednewdrugsorhavethemalreadyacaseofcoenzymeq10 AT monikaromanczyk heartfailuredoweneednewdrugsorhavethemalreadyacaseofcoenzymeq10 AT bogusławokopien heartfailuredoweneednewdrugsorhavethemalreadyacaseofcoenzymeq10 |